Treatment of acute myeloid leukemia, acute lymphoblastic leukemia and
acute T cell leukemia by Ag NP/chitosan-starch nano-biocomposite
Abstract
We herein demonstrate the biogenic nanoarchitechtonics of silver
nanoparticles template over chitosan/starch mixed hydrogel having
excellent reducing ability. The two biopolymers also had the capacity to
stabilize as-synthesized Ag NPs. Physicochemical and structural features
of the nanocomposite biomaterial was assessed by several techniques like
FT-IR, SEM, TEM, EDX and XRD. TEM study revealed the mean diameter of
the spherical shaped Ag NPs/CS-Starch material was in the range of 5-15
nm. Thereafter, the Ag NPs/CS-Starch bio-composite material was
exploited in the study of cytotoxicity and anti-leukemia effects against
diverse leukemia cell lines like acute myeloid leukemia (32D-FLT3-ITD
and Human HL-60/vcr), acute lymphoblastic leukemia (MOLT-3 and
TALL-104), and acute T cell leukemia (Jurkat, Clone E6-1 and J.RT3-T3.5)
in situ. Interestingly, the nano-drug could resist significantly against
those cell lines in a time and concentration-dependent manner, assessed
by MTT method. The corresponding IC50 values of the bio-composite were
203, 301, 250, 227, 102, and 193 µg/mL respectively against the cell
lines. Furthermore, antioxidant potential of the material was
investigated by DPPH radical scavenging method. A significantly high
IC50 value suggested the high antioxidant capacity of Ag NPs/CS-Starch
nanomaterial.